As the coronavirus pandemic continues to spread around the world, scientists and researchers are scrambling to find solutions to slow and/or cure the disease.
One Canadian doctor wants to conduct clinical trials on cannabinoids to see if cannabis compounds can help patients with COVID-19 reduce inflammation and boost their immune systems.
What we know about medical cannabis from the literature and the experience we have had in Canada over the years is that there are known anti-inflammatory properties of cannabinoids,” said Dr. Mohan Cooray, CEO of Catalog, an online retailer of medical cannabis.
In addition to this, we know from a medical point of view that these active ingredients have immunomodulatory properties, which means that they increase the immune system to make it better … and we have seen this in diseases such as Crohn’s disease, rheumatoid arthritis and multiple sclerosis where medical cannabis works as a natural immunomodulator.
Health Canada officials have not yet approved any clinical trials involving cannabinoids and VIDOC-19 treatment.
The IACM reminded last week that no studies have yet established that cannabis preparations can treat COVID-19 or protect against SARS-CoV2 infection.
Health precautions would also require cannabis users to avoid burning as much as possible, which irritates the lungs and could potentially aggravate coronavirus symptoms.